Leucocytosis associated with higher incidence of adverse cardiovascular events in myocardial infarcts;Leucocitosis y su asociación con eventos cardiovasculares adversos en sujetos con infarto y elevación de ST sometidos a intervención coronaria percutánea

Archivos de Cardiologia de Mexico

Volumn 75, Issue SUPPL. 3, 2005, Pages 61-68

  Comparan Núñez, Alfredo ^a   Palacios, Juan M ^a,b   Jerjes Sánchez, Carlos ^a,c,d  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b Laboratorio de Hemodinamia

^c Departamento de Urgencias   (Mexico)

^d NONE   (Mexico)

Author keywords

Acute coronary syndromes; Inflammation; Primary angioplasty; Risk stratification

Indexed keywords

ACUTE HEART INFARCTION; ACUTE PHASE RESPONSE; ADULT; AGE DISTRIBUTION; ARTICLE; ATHEROGENESIS; CARDIOGENIC SHOCK; CARDIOVASCULAR DISEASE; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMOGRAPHY; ENDOTHELIUM INJURY; FEMALE; FOLLOW UP; HEART DEATH; HEART MUSCLE PERFUSION; HEART MUSCLE REPERFUSION; HUMAN; LABORATORY TEST; LEUKOCYTE ACTIVATION; LEUKOCYTE COUNT; LEUKOCYTOSIS; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; NEUTROPHILIA; NON INSULIN DEPENDENT DIABETES MELLITUS; ST SEGMENT ELEVATION; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 28844436929     PISSN: 14059940     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. FURMAN MI, BECKER RC, YARZEBSKI J, SAVEGEAU J, GORE J, GOLDBERG R: Effect of elevated leukocyte count on in-hospital mortality following acute myocardial infarction. Am J Cardiol 1996; 78: 945-948.
2. LLOYD-JONES DM, CAMARGO JR CA, GIUGLIANO RP, O'DONNELL J: Effect of leukocytosis at initial examination on prognosis in patients with primary unstable angina. Am Heart J 2000; 139: 867-873.
3. CANNON CP, MCCABE CH, WILCOX RG, BENTLEY JH, BRAUNWALD E, for the OPUS-TIMI Investigators: Association of with blood cell count with increased mortality in acute myocardial infarction and unstable angina pectoris. Am J Cardiol 2001; 87: 636-639.
4. BARRON HV, CANNON CP, MURPHY SA, BRAUNWALD E, GIBSON MC: Association between with blood cell count epicardial blood flow, myocardial perfusion and clinical outcomes in the setting of acute myocardial infarction. Circulation 2000; 102: 2329-2334.
5. BARRON HV, HARR SD, RADFORD MJ, WANG Y, KRUMHOLZ HM: The association between white blood cell count and acute myocardial infarction in patients > 65 years of age: Findings from Cooperative Cardiovascular Project. J Am Coll Cardiol 2001; 38: 1654-1661.
6. SABATINE MS, MORROW DA, CANNON CP, MURPHY AS, DEMOPOULOS LA, DIBATTISTE PM, ET AL: Relationship between baseline white blood cell count and degree of coronary artery disease and mortality in patients with acute coronary syndromes. A TACTICS-TIMI 18 Substudy. J Am Cardiol 2002; 40: 1761-1768.
7. MEISEL C, AFSHAR-KHARGHAN V, CASCORBI I, LAULE M, STANGL V, FELIX SB, ET AL: Role of kozak sequence polymorphism of platelet glycoprotein Iba as a risk factor for coronary artery disease and catheter interventions. J Am Coll Cardiol 2001; 38: 1023-1027.
8. LOPEZ JA, DONG JF: Structure and function of the glycoprotein Ib-IX-V complex. Curr Opi Hematol 1997; 4: 323-329.
9. PELLIZZON GG, DIXON RS, STONE GW, COX DA, MATTOS L, BOURA JA, ET AL: Relation of admission white blood cell count to long - term outcomes after primary coronary angioplasty for acute myocardial infarction (The Stent PAMI Trial) for the Stent PAMI Investigators. Am Jour Cardiol 2003; 91: 729-731.
10. FRIEDMAN GD, KLASTSKY AL, SIEGELAUB AB: The leukocyte count as predictor of myocardial infarction. N Engl J Med 1974; 290: 1275-1278.
11. SCHLANT RC, FORMAN S, STAMLER J, CANNER PL: The natural history of coronary heart disease: prognostic factors after recovery from myocardial infarction in 2,789 men. The 5-year findings of the Coronary Drug Project. Circulation 1982; 66: 401-414.
12. SABATINE MS, MORROW DA, CANNON CP, MURPHY SA, DEMOPOULOS LA, DIBATTISTE PM, ET AL: Relationship between baseline white blood cell count and degree of coronary artery disease and mortality in patients with acute coronary syndromes. A TACTICS-TIMI 18 Substudy. J Am Coll Cardiol 2002; 40: 1761-1768.
13. Toss H, LINDAHL B, SIEGBAHN A, WALLENTIN L, for the FRISC Study Group: Prognostic influence of increased fibrinogen and C-reactive protein levels in unstable coronary artery disease. Circulation 1997; 96: 4204-4210.
14. LINDMARK E, DIDERHOLM E, WALLENTIN L, SIEGBAHN A: Relationship between interleukin-6 and mortality in patients with unstable coronary artery disease: effects of an early invasive or noninvasive strategy. JAMA 2001; 286: 2107-2113.
15. SOLODKY A, BERLINER S, SAFRIR H: Increased adhesiveness for peripheral blood leukocytes corresponds to the appearance of expansion following anterior wall myocardial infarction. Clin Cardiol 1996; 19: 102-103.
16. ANZAI T, YOSHIKAWA T, SHIRAKI H: C-reactive protein as a predictor or infarct expansion and cardiac rupture after a first Q-wave acute myocardial infarction. Circulation 1997; 96: 778-784.
17. IZAGUIRRE AR, ZALDIVAR AH: El fibrinógeno como factor de riesgo cardiovascular. Arch Cardiol Mex 2003; 73: 7-10.
18. KOENIG W: Fibrinogen in cardiovascular disease: an update. Thromb Haemost 2003; 89: 601-609.
19. POMAR FP, MARTÍNEZ JVA, PERIS DE, ECHANOVE EI, VILAR HJV, PÉREZ FE, ET AL: Valor pronóstico de la persistencia del segmento ST elevado después de una angioplastía primaria realizada con éxito. Rev Esp Cardiol 2002; 55: 816-822.